Heightened Scrutiny of Your Royal Highness On Sunday, March 10, tabloids were in quite a frenzy when the British royal family published a photoshopped picture of Catherine, princess of Wales. The hubbub was extra hubbubbly, because…
By Suzan Slijpen, Mauritz Kop & I. Glenn Cohen 1. Introduction: A Fragmented AI in Healthcare Regulatory Landscape In the past few years, we have witnessed a surge in artificial intelligence-related research and diagnostics in…
By Vincent Joralemon As therapies using drugs like MDMA, psilocybin, and LSD advance through the FDA research and approval pipeline, patients should be prepared for steep price tags attached to these procedures. For example, experts…
FDA rescheduling may provide a compelling model for efforts to decriminalize and destigmatize other substances moving forward.
By Hannah Rahim In January 2024, Pope Francis called for a universal ban on surrogacy as a threat to global peace and human dignity, claiming that the practice is a “grave violation” of the mother…
The existing organ allocation system has marginalized individuals diagnosed with psychotic or affective disorders.
Dr. Eunice Brookman-Amissah’s advocacy work contributed to a 40% reduction in deaths from unsafe abortion in sub-Saharan Africa since 2000.
Does organoid intelligence warrant recognition for the work it produces? And is that output protectible?
Lykos’ current application is based on MDMA-assisted therapy, and FDA will almost surely require that patients take the drug in a clinical setting.
The rise in polygenic embryo screening is ushering in a new era of human control over reproduction.
Notifications
